- Home
- LSTA vs AIIOW Comparison
LSTA vs AIIOW Comparison
Compare LSTA & AIIOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- AIIOW
- Stock Information
- Founded
- LSTA 1980
- AIIOW N/A
- Country
- LSTA United States
- AIIOW United Arab Emirates
- Employees
- LSTA N/A
- AIIOW N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- AIIOW Auto Manufacturing
- Sector
- LSTA Health Care
- AIIOW Industrials
- Exchange
- LSTA Nasdaq
- AIIOW Nasdaq
- Market Cap
- LSTA 22.3M
- AIIOW 19.0M
- IPO Year
- LSTA N/A
- AIIOW N/A
- Fundamental
- Price
- LSTA $2.17
- AIIOW $0.06
- Analyst Decision
- LSTA Strong Buy
- AIIOW
- Analyst Count
- LSTA 2
- AIIOW 0
- Target Price
- LSTA $23.50
- AIIOW N/A
- AVG Volume (30 Days)
- LSTA 25.5K
- AIIOW N/A
- Earning Date
- LSTA 08-07-2025
- AIIOW N/A
- Dividend Yield
- LSTA N/A
- AIIOW N/A
- EPS Growth
- LSTA N/A
- AIIOW N/A
- EPS
- LSTA N/A
- AIIOW N/A
- Revenue
- LSTA $1,070,000.00
- AIIOW N/A
- Revenue This Year
- LSTA N/A
- AIIOW N/A
- Revenue Next Year
- LSTA N/A
- AIIOW N/A
- P/E Ratio
- LSTA N/A
- AIIOW N/A
- Revenue Growth
- LSTA N/A
- AIIOW N/A
- 52 Week Low
- LSTA $1.87
- AIIOW N/A
- 52 Week High
- LSTA $4.20
- AIIOW N/A
- Technical
- Relative Strength Index (RSI)
- LSTA 37.46
- AIIOW N/A
- Support Level
- LSTA $2.55
- AIIOW N/A
- Resistance Level
- LSTA $2.63
- AIIOW N/A
- Average True Range (ATR)
- LSTA 0.17
- AIIOW 0.00
- MACD
- LSTA -0.04
- AIIOW 0.00
- Stochastic Oscillator
- LSTA 17.86
- AIIOW 0.00
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.